These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 411668)
1. Renin levels and spironolactone treatment in general practice: similar blood pressure lowering effect of spironolactone in low and normal renin patients. Sundsfjord JA; Odegaard AE Eur J Clin Invest; 1977 Oct; 7(5):389-92. PubMed ID: 411668 [TBL] [Abstract][Full Text] [Related]
2. Renin unresponsiveness and the effects of oxprenolol, methyldopa and spironolactone in pateints with essential hypertension. Thomas GW; Ledingham JG; Beilin LJ; Yeates KM Aust N Z J Med; 1976 Aug; 6(3 Suppl):44-8. PubMed ID: 798576 [TBL] [Abstract][Full Text] [Related]
3. Clinical and biochemical effects of spironolactone administered once daily in primary hypertension. Multicenter Sweden study. Scherstén B; Thulin T; Kuylenstierna J; Engström M; Karlberg BE; Tolagen K; Nordlander S; Nilsson G Hypertension; 1980; 2(5):672-9. PubMed ID: 6998872 [TBL] [Abstract][Full Text] [Related]
4. Spironolactone and hydrochlorothiazide in normal-renin and low-renin essential hypertension. Ferguson RK; Turek DM; Rovner DR Clin Pharmacol Ther; 1977 Jan; 21(1):62-9. PubMed ID: 318952 [TBL] [Abstract][Full Text] [Related]
5. The effect of spironolactone (Aldactone) and methyldopa in low and normal renin hypertension. Solheim SB; Sundsfjord JA; Giezendanner L Acta Med Scand; 1975 Jun; 197(6):451-6. PubMed ID: 1098396 [TBL] [Abstract][Full Text] [Related]
6. Renin concentrations and effects of propranolol and spironolactone in patients with hypertension. Karlberg BE; Kågedal B; Tegler L; Tolagen K Br Med J; 1976 Jan; 1(6004):251-4. PubMed ID: 764929 [TBL] [Abstract][Full Text] [Related]
7. Diuretic therapies in low renin and normal renin essential hypertension. Brooks CS; Johnson CA; Kotchen JM; Kotchen TA Clin Pharmacol Ther; 1977 Jul; 22(1):14-20. PubMed ID: 326459 [TBL] [Abstract][Full Text] [Related]
8. The spironolactone, amiloride, losartan, and thiazide (SALT) double-blind crossover trial in patients with low-renin hypertension and elevated aldosterone-renin ratio. Hood SJ; Taylor KP; Ashby MJ; Brown MJ Circulation; 2007 Jul; 116(3):268-75. PubMed ID: 17606839 [TBL] [Abstract][Full Text] [Related]
9. [Correlations between blood pressure, blood volume and plasma renin during therapy with diuretics in essential hypertension. Comparison between the mineralocorticoid antagonist spironolactone and the "loop" diuretic mefruside]. Beretta-Piccoli C; Weidmann P; de Châtel R; Hirsch D; Reubi FC Schweiz Med Wochenschr; 1977 Jan; 107(4):104-15. PubMed ID: 834983 [TBL] [Abstract][Full Text] [Related]
10. Failure of aspirin to antagonize the antihypertensive effect of spironolactone in low-renin hypertension. Hollifield JW South Med J; 1976 Aug; 69(8):1034-6. PubMed ID: 785608 [TBL] [Abstract][Full Text] [Related]
11. Comparison of chlorthalidone and spironolactone in low--renin essential hypertension. Kreeft JH; Larochelle P; Ogilvie RI Can Med Assoc J; 1983 Jan; 128(1):31-4. PubMed ID: 6336600 [TBL] [Abstract][Full Text] [Related]
12. Controlled treatment of primary hypertension with propranolol and spironolactone. A crossover study with special reference to initial plasma renin activity. Karlberg BE; Kågedal B; Tegler L; Tolagen K; Bergman B Am J Cardiol; 1976 Mar; 37(4):642-9. PubMed ID: 769527 [TBL] [Abstract][Full Text] [Related]
13. Response of blood pressure and the renin-angiotensin-aldosterone axis to hypotensive therapy: comparison of propranolol with spironolactone. Espiner EA; Mansfield H; Miles K N Z Med J; 1977 Sep; 86(595):216-9. PubMed ID: 343004 [No Abstract] [Full Text] [Related]
14. Antihypertensive responses to spironolactone in normal renin hypertension. Ogilvie RI; Piafsky KM; Ruedy J Clin Pharmacol Ther; 1978 Nov; 24(5):525-30. PubMed ID: 699476 [TBL] [Abstract][Full Text] [Related]
15. [Spironolactone and thiabutazide in the treatment of essential hypertension (author's transl)]. Klump F; Braun B; Klaus D; Lemke R; Zehner J; Zöfel P Dtsch Med Wochenschr; 1975 Mar; 100(12):577-84. PubMed ID: 1168122 [TBL] [Abstract][Full Text] [Related]
16. Does the aldosterone:renin ratio predict the efficacy of spironolactone over bendroflumethiazide in hypertension? A clinical trial protocol for RENALDO (RENin-ALDOsterone) study. Parthasarathy HK; Alhashmi K; McMahon AD; Struthers AD; Connell JM; McInnes GT; Ford I; MacDonald TM BMC Cardiovasc Disord; 2007 May; 7():14. PubMed ID: 17490489 [TBL] [Abstract][Full Text] [Related]
17. Effect of amiloride and spironolactone on renal tubular function and central blood pressure in patients with arterial hypertension during baseline conditions and after furosemide: a double-blinded, randomized, placebo-controlled crossover trial. Matthesen SK; Larsen T; Vase H; Lauridsen TG; Jensen JM; Pedersen EB Clin Exp Hypertens; 2013; 35(5):313-24. PubMed ID: 22966789 [TBL] [Abstract][Full Text] [Related]
18. Intrapatient comparison of treatment with chlorthalidone, spironolactone and propranolol in normoreninemic essential hypertension. Drayer JI; Kloppenborg PW; Festen J; van't Laar A; Benraad TJ Am J Cardiol; 1975 Oct; 36(5):716-21. PubMed ID: 1103606 [TBL] [Abstract][Full Text] [Related]
19. Studies on essential hypertension with suppressed plasma renin activity: sodium excretion pattern on salt restriction and effects of spironolactone on blood pressure and plasma renin activity. Uchida K; Morimoto S; Takeda R; Murakami M Jpn Circ J; 1972 Dec; 36(12):1301-11. PubMed ID: 4679217 [No Abstract] [Full Text] [Related]
20. [Use of spironolactone and indapamide in the treatment of low-renin arterial hypertension]. Naudzhunas A; Bagdonas G; Yankauskene L; Kazanavichus G Ter Arkh; 2006; 78(2):61-4. PubMed ID: 16613101 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]